Korean J Dermatol.  1996 Dec;34(6):1039-1043.

A Case of Diffuse Neonatal Hemangiomatosis Improved with Prednisolone and Interferon alfa - 2a

Affiliations
  • 1Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea.
  • 2Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Diffuse neonatal hemangiomatosis is a disease often with a fatal outcome, characterized by widespread capillary hemangiomias of the skin and visceral organs. A 6-month-old-girl was diagnosed to have diffuse neonatal hemangiomatosis by her multiple hemangiomas on the skin, liver, brain, lung and oral mucosa. She was treated with prednisolone 1.5-2mg/kg/day for 9 months and combined interferon alfa-2a 3 million unit/m2/day for 5months. During the treatment the number and size of hemangiomas were markedly reduced

Keyword

Diffuse neonatal henangiomatosis; Prednisolone; Interferon alfa-2a

MeSH Terms

Brain
Capillaries
Fatal Outcome
Hemangioma
Interferon-alpha*
Interferons*
Liver
Lung
Mouth Mucosa
Prednisolone*
Skin
Interferon-alpha
Interferons
Prednisolone
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr